ZY
Zymeworks
ZYME·NASDAQVancouver CAFounded 2003400 employees
Mid CapbiotechPublicOncology
Platform: Azymetric ADC
Market Cap
$2.5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ZYME)
Loading ZYME stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ZYM-2450 | ZYM-2450 | Phase 2 | 1 | GLP-1R | IPFCrohn's | ||
| ZYM-7428 | ZYM-7428 | Phase 1/2 | 2 | CGRP | RCC | ||
| Pemisertib | ZYM-256 | NDA/BLA | 1 | VEGF | MigrainePTSD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)